Israel - Tiếng Do Thái - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone furoate; umeclidinium as bromide; vilanterol as trifenatate - vilanterol as trifenatate 22 mcg/inh; umeclidinium as bromide 55 mcg/inh; fluticasone furoate 92 mcg/inh - vilanterol, umeclidinium bromide and fluticasone furoate

Israel - Tiếng Do Thái - Ministry of Health

gudovitch-bar ltd. - כלל האוכלוסיה - מוצרים להגנה על גדמים

Israel - Tiếng Do Thái - Ministry of Health

"קלינטיקה בע""מ" - אחר - פסי אספקה ושקעי גזים

Israel - Tiếng Do Thái - Ministry of Health

"קלינטיקה בע""מ" - אחר - פסי אספקה ושקעי גזים

Israel - Tiếng Do Thái - Ministry of Health

תעשיות חלב ת.מ.ח. בע"מ - קבוצת חכמי - רופא - סט צנרת דם לדיאליזה

Israel - Tiếng Do Thái - Ministry of Health

glaxo smith kline (israel) ltd - calcium carbonate 750 mg - tablets - calcium carbonate - treatment of heartburn, calcium supplement.

Israel - Tiếng Do Thái - Ministry of Health

glaxo smith kline (israel) ltd - ranitidine as hydrochloride - תמיסה להזרקה - ranitidine as hydrochloride 25 mg/ml - ranitidine - ranitidine - treatment of :- duodenal ulcer,- benign gastric ulcer,- post operative ulcer,- oesophageal reflux disease,- zollinger-ellison syndrome.before general anaesthesia in patients considered to be at risk of acid aspirationprophylaxis of stress ulceration in seriously ill patients.

Israel - Tiếng Do Thái - Ministry of Health

glaxo smith kline (israel) ltd - clobetasol 17- propionate - משחה - clobetasol 17- propionate 0.05 %w/w - clobetasol - clobetasol - resistant dermatoses responsive to potent corticosteroid therapy.

Israel - Tiếng Do Thái - Ministry of Health

glaxo smith kline (israel) ltd - clobetasol 17- propionate - קרם - clobetasol 17- propionate 0.05 %w/w - clobetasol - clobetasol - resistant dermatoses responsive to potent corticosteroid therapy.

Israel - Tiếng Do Thái - Ministry of Health

glaxo smith kline (israel) ltd - dutasteride - קפסולות רכות - dutasteride 0.5 mg - dutasteride - dutasteride - avodart monotherapy is indicated for : - treatment of moderate to severe symptoms of benign prostatic hyperplasia (bph).- prevention of acute urinary retention and surgery in patients with bph.avodart in combination with the alpha-blocker tamsulosin is indicated for : - treatment of moderate to severe symptoms of benign prostatic hyperplasia (bph).